Abstract:Because host kinases are key regulators of multiple signaling pathways in response to viral infections, we previously screened a kinase inhibitor library using rhabdomyosarcoma cells and human intestinal organoids in parallel to identify potent inhibitors against EV-A71 infection. We found that Rho-associated coiled-coil-containing protein kinase (Rock) inhibitor efficiently suppressed the EV-A71 replication and further revealed Rock1 as a novel EV-A71 host factor. In this study, subsequent analysis found that a variety of vascular endothelial growth factor receptor (VEGFR) inhibitors also had potent antiviral effects. Among the hits, Pazopanib, with a selectivity index as high as 254, which was even higher than that of Pirodavir, a potent broad-spectrum picornavirus inhibitor targeting viral capsid protein VP1, was selected for further analysis. We demonstrated that Pazopanib not only efficiently suppressed the replication of EV-A71 in a dose-dependent manner, but also exhibited broad-spectrum anti-enterovirus activity. Mechanistically, Pazopanib probably induces alterations in host cells, thereby impeding viral genome replication and transcription. Notably, VEGFR2 knockdown and overexpression suppressed and facilitated EV-A71 replication, respectively, indicating that VEGFR2 is a novel host dependency factor for EV-A71 replication. Transcriptome analysis further proved that VEGFR2 potentially plays a crucial role in combating EV-A71 infection through the TSAd-Src-PI3K-Akt pathway. These findings expand the range of potential antiviral candidates of anti-enterovirus therapeutics and suggest that VEGFR2 may be a key host factor involved in EV-A71 replication, making it a potential target for the development of anti-enterovirus therapeutics. Importance: As the first clinical case was identified in the United States, EV-A71, a significant neurotropic enterovirus, has been a common cause of hand, foot, and mouth disease (HFMD) in infants and young children. Developing an effective antiviral agent for EV-A71 and other human enteroviruses is crucial, as these viral pathogens consistently cause outbreaks in humans. In this study, we demonstrated that multiple inhibitors against VEGFRs effectively reduced EV-A71 replication, with Pazopanib emerging as the top candidate. Furthermore, Pazopanib also attenuated the replication of other enteroviruses, including CVA10, CVB1, EV-D70, and HRV-A, displaying broad-spectrum anti-enterovirus activity. Given that Pazopanib targets various VEGFRs, we narrowed the focus to VEGFR2 using knockdown and overexpression experiments. Transcriptomic analysis suggests that Pazopanib's potential downstream targets involve the TSAd-Src-PI3K-Akt pathway. Our work may contribute to identifying targets for antiviral inhibitors and advancing treatments for human enterovirus infections.

The Highly Conserved 5' Untranslated Region As an Effective Target Towards the Inhibition of Enterovirus 71 Replication by Unmodified and Appropriate 2'-Modified Sirnas.

In Vitro and in Vivo Protection Against Enterovirus 71 by an Antisense Phosphorothioate Oligonucleotide

IRES-targeting small molecule inhibits enterovirus 71 replication via allosteric stabilization of a ternary complex

MicroRNAs miR-18a and miR-452 regulate the replication of enterovirus 71 by targeting the gene encoding VP3

Vascular endothelial growth factor receptor 2 as a potential host target for the inhibition of enterovirus replication

Sirt1 Inhibits Ev71 Genome Replication and Rna Translation by Interfering with the Viral Polymerase and 5 ' Utr Rna

Human MicroRNA hsa-miR-296-5p Suppresses Enterovirus 71 Replication by Targeting the Viral Genome

The Untranslated Regions of EV-A71 Contribute to Its Pathogenicity and Virulence.

Reverse Genetic Approaches for the Generation of Full Length and Subgenomic Replicon of EV71 Virus.

An adenosine nucleoside analogue NITD008 inhibits EV71 proliferation

Inhibition of viral suppressor of RNAi proteins by designer peptides protects from enteroviral infection in vivo

Transient Inhibition of Foot-and-mouth Disease Virus Replication by Sirnas Silencing VP1 Protein Coding Region.

Honeysuckle-encoded microRNA2911 inhibits Enterovirus 71 replication via targeting VP1 gene

In Vitro Assessment of Combinations of Enterovirus Inhibitors Against Enterovirus 71

Inhibition of Enterovirus 71 Replication by an Α-Hydroxy-nitrile Derivative NK-1.9k

Hsa-let-7c-5p Augments Enterovirus 71 Replication Through Viral Subversion of Cell Signaling in Rhabdomyosarcoma Cells.

The Upregulation of a Novel Long Noncoding RNA AK097647 Promotes Enterovirus 71 Replication and Decreases IFN-λ1 Secretion.

Prediction for Target Sites of Small Interfering RNA Duplexes in Enterovirus 71

Long non-coding RNA ENST00000469812 promotes Enterovirus type 71 replication via targeting the miR-4443/NUPR1 axis in rhabdomyosarcoma cells

Inhibition of Food-and-mouth Disease Virus by Sirnas Targeting IRES Sequence in Vitro

New Potent EV-A71 Antivirals Targeting Capsid.